The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...

Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing a novel and differentiated inhaled therapeutic ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

A new paper in Environmental Toxicology and Chemistry finds that common medications used for flea and tick control in dogs ...

Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal ...

A new randomized controlled trial has found promising evidence that the smoking cessation medication varenicline ...

Timing of consolidation durvalumab significantly impacts survival for patients with locally advanced non-small cell lung ...

Revolution Medicines surged on AbbVie buyout rumors but pulled back after denial. Learn what's next for RVMD stock and why it ...

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...

A Pasadena firefighter who battled the Eaton Fire says a detox program lowered toxin levels in his blood, offering hope amid ...

RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...